Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Azurocidin 1 pseudogene 1 (AZU1P1) is a non-functional genomic sequence related to the protein-coding gene AZU1 (Azurocidin 1). While AZU1 encodes an antimicrobial and monocyte chemotactic protein involved in innate immunity, host defense, and inflammation, AZU1P1 itself encodes no functional protein product and has no recognized biological, disease, or pharmacological function. It is not considered a protein, receptor, enzyme, or therapeutic target, and should not be confused with the functional Azurocidin 1 gene or protein[1][2][3][4][6][7]. Critical clarification: If you are seeking actionable information or potential as a therapeutic target, you likely meant to ask about Azurocidin 1 (AZU1), not its pseudogene AZU1P1. All recognized research, clinical associations, immune functions, and drug relevance pertain to AZU1, not to AZU1P1, which has no such significance.
None (no protein product)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Azurocidin 1 pseudogene 1 (AZU1P1).